Birnbaum G, Kotilinek L, Schlievert P, Clark H B, Trotter J, Horvath E, Gao E, Cox M, Braun P E
Department of Neurology, University of Minnesota, Minneapolis 55455, USA.
J Neurosci Res. 1996 May 15;44(4):381-96. doi: 10.1002/(SICI)1097-4547(19960515)44:4<381::AID-JNR10>3.0.CO;2-5.
We describe sequence similarity and immunologic cross-reactivity between a peptide of the mycobacterial hsp, HSP65, and the myelin protein 2',3' cyclic nucleotide 3' phosphodiesterase (CNP). We demonstrate that immunization with the homologous cross-reactive CNP peptide (hsp-CNP peptide) has significant biological consequences. Rats immunized with hsp-CNP peptide in either complete Freund's adjuvant (CFA) or incomplete Freund's adjuvant (IFA) produce large amounts of peptide-specific antibody. Isotypes of antibodies in animals immunized with peptide in CFA are IgG1 and IgG2a. Isotypes of antibodies in rats immunized with peptide in IFA are predominantly IgG1, with low titers of IgG2a. T cell proliferative responses to HSP65 are present in rats immunized with peptide in CFA. T cell responses to HSP65 initially are absent in rats immunized with peptide in IFA but develop over time. T cell proliferative responses to hsp-CNP peptide were not detected. None of the groups of rats developed clinical or histologic evidence of experimental autoimmune encephalomyelitis (EAE). To induce EAE, rats preimmunized with hsp-CNP peptide were challenged with guinea pig spinal cord (GPSC) emulsified in CFA. Rats preimmunized with peptide in CFA developed severe EAE. Rats preimmunized with hsp-CNP peptide in IFA were protected from EAE, with both a lower incidence and severity of disease. Injecting the murine monoclonal antibody recognizing the shared HSP65 and CNP epitope did not protect against EAE. Our data suggest that a Th2 pattern of immune response to a CNP peptide that itself is non-encephalitogenic protects against EAE. Immune responses to either hsp or myelin proteins cross-reactive with hsp may play an important role in the development of EAE.
我们描述了分枝杆菌热休克蛋白HSP65的一种肽与髓磷脂蛋白2',3'环核苷酸3'磷酸二酯酶(CNP)之间的序列相似性和免疫交叉反应性。我们证明,用同源交叉反应性CNP肽(hsp-CNP肽)免疫会产生显著的生物学后果。用hsp-CNP肽在完全弗氏佐剂(CFA)或不完全弗氏佐剂(IFA)中免疫的大鼠会产生大量肽特异性抗体。在CFA中用肽免疫的动物体内抗体的同种型为IgG1和IgG2a。在IFA中用肽免疫的大鼠体内抗体的同种型主要为IgG1,IgG2a的滴度较低。在CFA中用肽免疫的大鼠对HSP65有T细胞增殖反应。在IFA中用肽免疫的大鼠最初对HSP65没有T细胞反应,但随着时间的推移会产生。未检测到对hsp-CNP肽的T细胞增殖反应。所有大鼠组均未出现实验性自身免疫性脑脊髓炎(EAE)的临床或组织学证据。为了诱导EAE,用hsp-CNP肽预先免疫的大鼠用CFA乳化的豚鼠脊髓(GPSC)进行攻击。在CFA中用肽预先免疫的大鼠发生了严重的EAE。在IFA中用hsp-CNP肽预先免疫的大鼠对EAE有保护作用,疾病的发病率和严重程度均较低。注射识别共同的HSP65和CNP表位的鼠单克隆抗体不能预防EAE。我们的数据表明,对本身无致脑炎性的CNP肽的Th2型免疫反应可预防EAE。对hsp或与hsp交叉反应的髓磷脂蛋白的免疫反应可能在EAE的发生发展中起重要作用。